tel: fax: FACSIMILE TRANSMISSION Date: Siu PLEASE DELIVER ATTACHED MESSAG 10: SelCpe MsTeiv FAX #: TEL #: Regarding: Number of pages (including cover page): a Remarks: | abed VESISBEZIZL Ypsiy AUeH WA/EGO 9102 60 Sny EFTA00282981

--=PAGE_BREAK=--

oe 6 CPT CODE | wr | - ry | NER Hn ANRC pal in the treatment of symptomatic BPI, LOWER THEIR SCORE in Ag ay Lies emi - Testes Shaty Groep. 7 “ . ole of Derege crt f LOMAX Gyrretumete BPH) ou. Orson BMSUOSIV Fe " PEQISBEZIZL Ypsiy AueH WAVEGO 9102 60 Sny EFTA00282982

--=PAGE_BREAK=--



--=PAGE_BREAK=--

BigReference | FINAL REPORT LABORATORIES FISCH, HARRY HARRY FISCH, M.D. EPSTEIN,| JEFFREY DO8:01/28/1953 Age:63 Y Sex:M Address:P E 71ST STREET New York, NY 10828 NEW YO! P| #: — si : ( ies P: Specimen ID: 165819158 Date Of Report: 67/23/2616 Date Collected: 67/20/2616 Time Collected: 68:52 Date Received: 67/20/2016 Time Received: 23:20 North America Eastern Time Creatinine . i . ALT 42 HI Cholesterol i HDL CHOL., DIRECT 28 LO HDL as % of Chol/HDL Ratip 7.5 Cholesterol MCHC Hemoglobin Aic NON FASTING STRY Ya ee * 24 Matal Protein @ 2 [Albumin : < 32 x | 4.2 01/27/2016 7 Globulin . 1.7-3. g/dl [2.5 |el/27/2e16 A/G Ratio : 1.1-2.9 1.7 @1/27/2016 Glucose 78-99 mg/dL i 99 01/27/2616 Sodium 135-147 mnol/L 141 @1/2772016 Chloride | 96-108 mmol/L | 102 [81/27/2016 [co2 [22-29 molt T2621 /27/2016 BUN mg/dL 01/27/2016 Creatinine me/dt aa 81/27/2016 re-GFR mL/min 0172772016 e-GFR, African American a mL/min 01/27/2016 BUN/Creat Ratio ie.0-28.0 01/27/2016 Calcium 8.6-10.4 mg/dL 01/27/2016 | Uric Acid 3.4-8.5 mg/dL 81/27/2616 | [Iron 45-160 ug/dL 01/27/2016 | Bilirubin, Total <1.2 /di 01/27/2016 | fib - - 135-225. U/L 81/27/2016 Alk Phos 48-156 U/L 01/27/2016 | AST <40 w/t [3 04/27/2016 | Phosphorus 2.7-4.5 mg/dl 81/27/2016 [ALT <41 U/L 01/27/2016 Gate 10-71 U/L |@1727/2016 | ARDIOVASCULAR, Cholesterol tttstStS 210 HI "20 ~ -443———«(@1/27/2 Triglycerides 9508 HI <158 1/27/2816 NOTE: The result for Triglycerides has been confirmed by repeat analysis. HOL CHOL., DIRECT 28 LO 48 81/27/2816 HOL as % of Cholesterol B “>i4 ~ 81/27/2016 | Evaluation: ABOVE AVG. (MODERATE RISK) [Chol /HDL Ratio 7.5 <7.4 6.8 81/27/2016 SioReference Laboratorie: James Weisberger, #.0. Clinical Page 1 of 6 481 Edward H. Ross Dr | I Laboratory Director Printed 67/25/2016 67:01 py abed VEQIBBEZIZL Psy AUPH WaESO 9102 60 ny EFTA00282984

--=PAGE_BREAK=--

BioReference FINAL REPORT LABORATORIES JEFFREY p/1953 Age:63 Y Sex:M p & 71ST STREET Specimen ID: 165819158 Date Of Report: 87/23/2¢16 Date Collected: @7/20/2@16 Time Collected: @8:52 Date Received: @7/20/2016 Time Received: 23:20 FISCH, HARRY HARRY FISCH, M.D. New York, NY 10028 Acct_#: i $i P: North America Eastern Time : tay Evaluation: ABOVE (MODERATE RISK) [LDL/HDL Ratio Can*t Calc <3.56 Calc [1/27/2016 LOL Cholesterol Can't Cale <168 mg/dl Calc |@1/27/2816 NOTE: Unable to calculate LOL due to a Iriglyceride jevel of greater than 4@0 mg/dL. | 7-32 me/dt L_Can*t Cale {01/27/2016 | Can't Cale: One or more components was outside the measurable range. We are unable to calculate. Can't Calc VLDL, CALCULATED WAC . 3,66-11,99 x10(3)/ul_ | -7.12~—~—=«@1/27/2016 RBC : 4.20-5.58 x10(6)/uL 4.96 01/27/2016 HGB 12.3-17.8 gmn/dL 14,3 01/27/2016 HCT 39.3-52.5 | 41.3————([1/27/2016 MeV ~ 83-3 _Jet/27/2016 MCH 01/27/2016 MCHC ~ 35.2 HI 0-35. ‘gn : 01/27/2016 ROW 01/27/2016 | POLYS @1/27/2016 TLYMPHS 01/27/2016 MONOS 01/27/2016 | EOS 01/27/2016 | BASOS ~~ - 81/27/2016 | 81/27/2016 | IMMATURE GRANULOCYTES PLATELET COUNT MPV 8.9 8.2-11.9 L NOTE; New reference ranges for WBC and Absolute counts are effective 4/25/2016. |PT TNP 9.1-11.9 sec Test Not Performed: Specimen REJECTED for testing due to GROSS LIPEMIA. INTR.NORM, RATIO(INR) “TNP __2,08-3.08 : PTT TNP 23.6-31.6 sec 5 URINALYSIS Color YELLOW YELLOW, STRAN, AMBER Character CLEAR Oo CLEAR | Specific Gravity Ur 1,025 1.063 - 1.638 | [pH Urine SS Be Protein, Urine NEGATIVE NEGATIVE | Glucose, Urine NEGATIVE NEGATIVE |Ketone, Urine NEGATIVE - NEGATIVE [ [Urobilinogen Urine 620 6.2 - 1.8 mg/d | | —=~<C BioReference Laboratorie James Weisberger, M.D. Clinical Page 2 of 6 481 Edward H. Ross Dr | ei | Laboratory Director Printed 07/25/2616 7:01 g abed VESISBEZIZL YPsiy AWEH WdBESO 9102 60 Bny EFTA00282985

--=PAGE_BREAK=--

BioRefe: LABORATORIES FISCH, HARRY HARRY FISCH, M.D. New York, NY 10028 Acct_#: 1726-1) P: si Bilirubin, Urine Blood, Urine Nitrites Urine EPSTEIN, DOB :01/2! Address: NEGAT NEGATIVE NEGATIVE JEFFREY {1953 Age:63 Y Sex:M E 71ST STREET i — NEGATIVE NEGATIVE NEGATIVE NEGATIVE Leukocyte Esterase — Crystals Urine Crystal Amt. Urine WBC, Urine RBC, Urine aE e-4 NONE SEEN Epithelial Cells, Ur Cast, Hyaline, Urine Cast, Granular, Ur Cast, RBC, Urine NONE 3-4 NONE SEEN NONE SEEN NONE FINAL REPORT Specimen ID: 165819158 Date Of Report: 67/23/2016 Date Collected: 67/20/2616 Time Collected: 68:52 Date Received: 07/28/2016 Time Received: 23:20 North America Eastern Time NONE 0-4 NONE SEEN PER HPF PER LPF PER LPF PER LPF Bacteria, Urine BIOL( CULTURE, URINE | SITE: URINE Hemoglobin Alc HEMOGLOBIN Alc AND e€AG REFERENCE RANGES NO GROWTH Alc (%) DIABETES CATEGORY* <5.7 Normal (nop-ciabetic) 5.7-6.4 Increased tise of diabetes =>6.5 Consistent |with diabetes A1c(%) eAG(ESTIMATED AVERAGE PLASMA GLUCOSE) (mg/dL) 6 126 7 1s4 8 183 9 212 1 240 11 269 12 298 *recommended ranges-American Diabetes Association(2610) Test Not Performed: Specimen rejected for testing du@¢ to moderate or marked Laboratory Director James Weisberger, M.D. 1/27/2016 NOTE: Hemolysis, rare hemoglobin variants and thalas$emia major may affect glycemic results. TSH TNP @.178-4.53@ uIU/mL 1.798 61/27/2016 | Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. Thyroxine(T4) TNP 4.9-12.9 ug/db 6.3 61/27/2816 | Clinical Page 3 of 6 Printed 67/25/2816 97:01 BioReference Laboratorie 4B1 Edward H. Ross Dr | 7 g abed VESISBEZIZL YPsiy AWeH WH6EGO 9102 60 Sny EFTA00282986

--=PAGE_BREAK=--

. FINAL REPORT BigReference LABO ATORIES Ai FISCH, HARRY 0 HARRY _F H, M.D. JEFFREY p/1953 Age:63 Y Sex: Specimen ID: 185819158 Date Of Report: 87/23/2016 » E 71ST STREET Date Collected: 87/26/2016 New York, NY 10028 NY_10021 Time Collected: 88:52 Acct_#: _(€1720-1) S1. : >, Date Received: @7/20/2016 P: ; Time Received: 23:20 Worth America Eastern Time CLINICAL REPORT hemolysis. T3 Uptake(T3U) TNP 24.3-39.0 % . 61/27/2016 | Test Not Performed: Specimen rejected for testing cu¢ to moderate or marked } hemolysis. THYROXINE, FREE(FT4) TNP | @.88-1.73 ng/dl Test Not Performed: Specimen rejected for testing du¢ to moderate or marked 6.93 61/27/2016 hemolysis. FREE 14 INDEX TNP 5-3.8 T 8 1/27/2016 | T3(THYRONINE), TOTAL TNP 72-180 ng/g 127 @1/27/2016 Test Not Performed: Specimen rejected for testing du¢ toe moderate or marked hemolysis. PSA Total TNP <4,20 ng/ml | 6.76 @1/27/2016 Test Not Performed: Specimen rejected for testing du¢ to moderate or marked hemolysis. NOTE: The PSA assay should not be the only test used|for diagnostic purposes. | Additional evaluation using ORE, ultrasound, TWR or similar procedures may be used for this purpose. Predictions of diseage recurrence should not be based solely upon values obtained from serial SA values obtained on the patient. NOTE: Values obtained with different assay methods of kits cannot be used interchangeably. NOTE; Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease. | ASSAY INFORMATION: Method Electrochemiluminescence Immunoassay (Roche Diagnostics) PSA, FREE “TN Not Estab. ng/al [6-33 18172772616 Test Not Performed: Specimen rejected for testing due to moderate or marked | hemolysis. | NOTE; Results cannot be interpreted as absclute evidence of the presence or absence of malignant disease. Values obtained with different assay methods or kits cannot be/used interchangeably. | ASSAY INFORMATION: Method Electrochemiluminescence I unoas say (Roche Diagnostics). % FREE PSA TNP See Below % 47 61/27/2816 FREE PSA RISK ASSESSMENT The probability of prostate cancer for men with noh-suspicious DRE results, by age group, using PSA values between 4.000 and 10.066 ng/mL and percent FREE PSA values 1s summarized in the table below: BioReference Laboratorie James Weisberger, M.D. Clinical Page 4 of 6 481 Edward H. Ross Dr | | Laboratory Director Printed 07/25/2016 67:01 2 abed VEQIBBEZIZL “Sly AUEH WdOv'SO 9102 60 GSny EFTA00282987

--=PAGE_BREAK=--

FINAL REPORT BioReference — we aa, LABORATORIES FISCH, HARRY New York, NY 16028 Acct_#: a : ) P: EPSTEIN, | JEFFREY 9/1953 Age:63 Y Sex:l E 71ST STREET NY_ 10021 Specimen ID: 105819158 Date Of Report: 67/23/2016 Date Collected: 87/20/2016 Time Collected: 08:52 Date Received: 27/26/2016 Time Received: 23:26 North America Eastern Time est: ite aE PROBABILITY OF CANCER* KFree PSA (50-59 yrs) (68-69 yrs) (>0r=7@ yrs) <ore18 49.2% 57.5% 64.5% | 11-18 26.9% 33.9% 40.8% 19-25 18.3% 23.9% 29.7% >25 9.1% 12.2% 15.8% *probability of finding prostate cancer by needie biopsy NOTE: Calculation of percent FREE PSA may not be pos TOTAL PSA is in the low normal range. These gu ! performed using the Roche £682 immuncassay sys ible when the value for delines are for assays em, (8/2815 ;V8.2) TESTOSTERONE, TOT.,S. TNP 193.0-740.0 ng/db 296.8 |@1/27/2016 | Test Not Performed: Specimen rejected for testing du¢ to moderate or marked | hemolysis. TESTOSTERONE, BIOAVAIL. _TNP - ~_-72,8-460.0 _ng/dt 183.8 SEX HORM.BIND.GLOB. TWP 16-57 nmol/L 18 172772016 | Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. FREE TESTOSTERONE TNP ; ; 38. 68-158.08 pg/mL LH TNP 1.7-8.6 mIU/mL 6.8 @1/27/2016 Test Not Performed: Specimen rejected for testing due to moderate or marked hemolysis. [FSH TWP 1.5-12.4 wmlU/mt 6.8 @1/27/2816 | Test Not Performed: Specimen rejected for testing dup to moderate or marked | hemolysis. PROLACTIN, SERUM TNP 4.0-15.2 ng/mt. 3.810 1/27/2016 | Test Not Performed: Specimen rejected for testing dup to moderate or marked hemolysis. [ESTRADIOL ~TNP ~ 7,02-49.06 pg/mL 48.93 —-([@1/27/2016 Test Not Performed: Specimen rejectec for testing dup to moderate or marked hemolysis. FIBRINOGEN TNP 176-441 g/dL [276 —_—«*(e1/27/2016 DIHYDROTESTOSTERONE (7) 148 .@ 106-719 pg/mL 106.8-719,.@ pg/mL (7) Performed by: Reference Intervals for Males age 2@ years and above): Analysis by High Performance Liquid Chromatography/ TandemMass Spectromet (LC-MS/MS) National Medical Lab 2300 Stratford Ave. Willow Grove, PA 19899 BioReference Laborator: 481 Edward H. Ross Dr James Weisberger, M.D. Laboratory Director Clinical Page 5 of 6 Printed 07/25/2016 @7:¢1 pESISREZIZL Sly AUeH WdOv'GO 9102 60 Sny EFTA00282988